LYCOS RETRIEVER 
Zyprexa: Eli Lilly
built 656 days ago
Since the year 2000 the warning signs for Zyprexa have been surfacing, but Eli Lilly didn’t begin to acknowledge the problems until much later when the FDA intervened. In fact, the FDA finally had to order drug maker Eli Lilly to change the label, warning patients of the dire complications as a result of the drug. Hundreds of patients had adverse reactions and reported complaints of hyperglycemia, diabetes, ketoacidosis, pancreatitis and other related conditions.
Source:
Zyprexa is an antipsychotic medication produced by the pharmaceutical company Eli Lilly. In 1996 the FDA approved Zyprexa to treat the adverse symptoms associated with schizophrenia and bipolar disorder. Since Zyprexa's approval, reports of serious and deadly side effects have been revealed in addition to reports of death from a Zyprexa overdose.
Source:
Zyprexa represents about one-third of Eli Lilly’s 4.3 billion in sales last year. While Eli Lilly continues to enjoy the profits from Zyprexa sales, patients continue to suffer from the known and newly discovered health risks associated with the drug. Brown & Crouppen believes that the dangers of Zyprexa will increase as the drug remains in use at nursing homes and hospitals to treat the outbursts of the mentally ill and elderly.
Source:
In September 2003, the FDA required that atypical antipsychotic drugs, including Eli Lilly’s Zyprexa, should include updated labeling that informs users of the suggested link between these drugs and the risk for diabetes and hyperglycemia (4). The requested labeling ... suggests that diabetics and those patients with diabetic risk factors be tested for blood sugar abnormalities. The FDA was spurred to action by the increasing numbers of epidemiological studies that link atypical antipsychotic use to an increase in hyperglycemia-related adverse events. On March 1, 2004, Eli Lilly announced in a letter to healthcare professionals their intention to comply with these labeling suggestions (5).
Source:
Zyprexa was approved for use by the U.S. Food and Drug Administration (FDA) in 1996. In 2006 Zprexa was Lilly's top selling drug, earing $4.2 billion for the company, a 4% increase on sales in 2005. Of the gobal sales, $2.1 billion was from the US and $US2.257 billion from the rest of the world. Sales of Zyprexa are critical to the company. In 2006 Zprexa generated revenues over three times as much as the company's next biggest drug, Gemzar.
Source:
"Zyprexa was approved by the FDA in 1996 and remains on the market today. It has been the subject of nearly 100 studies over the past 23 years and has been used by more than 20 million people worldwide. Doctors continue to prescribe it to deal with some of the most terrible mental illnesses, such as schizophrenia and bipolar disorder. The FDA has looked at the entire body of evidence that Lilly has continued to provide over the years, and has affirmed the benefit that this medicine can give to patients when accompanied by appropriate labeling regarding benefits and risks.
Source:
MORE ABOUT
Eli Lilly